125 related articles for article (PubMed ID: 3876336)
41. Cytoplasmic and nuclear androgen receptor content of normal and neoplastic human prostates and lymph node metastases of human prostatic adenocarcinoma.
Shain SA; Boesel RW; Lamm DL; Radwin HM
J Clin Endocrinol Metab; 1980 Apr; 50(4):704-11. PubMed ID: 6154061
[No Abstract] [Full Text] [Related]
42. Hormonal regulation in two rat mammary cancer cell lines: glucocorticoid and androgen receptors.
Vignon F; Chan PC; Rochefort H
Mol Cell Endocrinol; 1979 Feb; 13(2):191-202. PubMed ID: 109329
[TBL] [Abstract][Full Text] [Related]
43. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP.
Swinnen JV; Van Veldhoven PP; Esquenet M; Heyns W; Verhoeven G
Endocrinology; 1996 Oct; 137(10):4468-74. PubMed ID: 8828509
[TBL] [Abstract][Full Text] [Related]
44. Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor.
Heisler LE; Evangelou A; Lew AM; Trachtenberg J; Elsholtz HP; Brown TJ
Mol Cell Endocrinol; 1997 Jan; 126(1):59-73. PubMed ID: 9027364
[TBL] [Abstract][Full Text] [Related]
45. Androgen receptor in rat skeletal muscle: characterization and physiological variations.
Michel G; Baulieu EE
Endocrinology; 1980 Dec; 107(6):2088-98. PubMed ID: 6968675
[TBL] [Abstract][Full Text] [Related]
46. Human breast cancer: androgen action mediated by estrogen receptor.
Zava DT; McGuire WL
Science; 1978 Feb; 199(4330):787-8. PubMed ID: 622569
[TBL] [Abstract][Full Text] [Related]
47. Dunning adenocarcinoma in tissue culture: isolation of a cloned cell line, R3327H-G8-A1.
Sestili MA; Norris JS; Lipschultz LI; Smith RG
J Urol; 1982 Apr; 127(4):823-5. PubMed ID: 7040704
[TBL] [Abstract][Full Text] [Related]
48. Androgens regulate vascular endothelial growth factor content in normal and malignant prostatic tissue.
Joseph IB; Nelson JB; Denmeade SR; Isaacs JT
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2507-11. PubMed ID: 9815654
[TBL] [Abstract][Full Text] [Related]
49. Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations.
Lyng FM; Jones GR; Rommerts FF
Biol Reprod; 2000 Sep; 63(3):736-47. PubMed ID: 10952915
[TBL] [Abstract][Full Text] [Related]
50. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.
Kokontis JM; Hay N; Liao S
Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399
[TBL] [Abstract][Full Text] [Related]
51. Regulation of the androgen and glucocorticoid receptors in rat and mouse skeletal muscle cytosol.
Dahlberg E; Snochowski M; Gustafsson JA
Endocrinology; 1981 Apr; 108(4):1431-40. PubMed ID: 6970661
[TBL] [Abstract][Full Text] [Related]
52. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
Zhao XY; Ly LH; Peehl DM; Feldman D
Endocrinology; 1997 Aug; 138(8):3290-8. PubMed ID: 9231780
[TBL] [Abstract][Full Text] [Related]
53. [Androgen regulation of secreted growth factors in prostate carcinoma cell and tumor lines].
Kellner U; Wagner B; Otto U; Voigt KD; Dietel M; Knabbe C
Verh Dtsch Ges Pathol; 1993; 77():124-8. PubMed ID: 7511269
[TBL] [Abstract][Full Text] [Related]
54. Physicochemical characterization of the androgen receptor from hyperplastic human prostate.
Murthy LR; Chang CH; Rowley DR; Scardino PT; Tindall DJ
Prostate; 1984; 5(6):567-79. PubMed ID: 6208540
[TBL] [Abstract][Full Text] [Related]
55. Negative controls of cell proliferation: human prostate cancer cells and androgens.
Sonnenschein C; Olea N; Pasanen ME; Soto AM
Cancer Res; 1989 Jul; 49(13):3474-81. PubMed ID: 2731169
[TBL] [Abstract][Full Text] [Related]
56. Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA.
Yuan S; Trachtenberg J; Mills GB; Brown TJ; Xu F; Keating A
Cancer Res; 1993 Mar; 53(6):1304-11. PubMed ID: 8443809
[TBL] [Abstract][Full Text] [Related]
57. The response of extracellular signal-regulated kinase (ERK) to androgen-induced proliferation in the androgen-sensitive prostate cancer cell line, LNCaP.
Bell WC; Myers RB; Hosein TO; Oelschlager DK; Grizzle WE
Biotech Histochem; 2003 Feb; 78(1):11-6. PubMed ID: 12713136
[TBL] [Abstract][Full Text] [Related]
58. The xenoestrogen bisphenol A induces inappropriate androgen receptor activation and mitogenesis in prostatic adenocarcinoma cells.
Wetherill YB; Petre CE; Monk KR; Puga A; Knudsen KE
Mol Cancer Ther; 2002 May; 1(7):515-24. PubMed ID: 12479269
[TBL] [Abstract][Full Text] [Related]
59. Rapid signalling by androgen receptor in prostate cancer cells.
Peterziel H; Mink S; Schonert A; Becker M; Klocker H; Cato AC
Oncogene; 1999 Nov; 18(46):6322-9. PubMed ID: 10597231
[TBL] [Abstract][Full Text] [Related]
60. Androgens down-regulate the expression of the human homologue of paternally expressed gene-3 in the prostatic adenocarcinoma cell line LNCaP.
Ulrix W; Swinnen JV; Heyns W; Verhoeven G
Mol Cell Endocrinol; 1999 Sep; 155(1-2):69-76. PubMed ID: 10580840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
